CTLN2 is characterized by markedly high levels of L-citrulline in both the liver and blood of affected patients with a severe Citrin deficiency (CD) [130–134]. This evidence concerns the gene SLC25A13 and hyperinsulinemic hypoglycemia, familial, 4.